Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020772

« Back to Dashboard
NDA 020772 describes SUCRAID, which is a drug marketed by Qol Medcl and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the SUCRAID profile page.

The generic ingredient in SUCRAID is sacrosidase. One supplier is listed for this compound. Additional details are available on the sacrosidase profile page.

Summary for NDA: 020772

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Enzyme Replacements/Modifiers

Pharmacology for NDA: 020772

Suppliers and Packaging for NDA: 020772

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SUCRAID
sacrosidase
SOLUTION;ORAL 020772 NDA QOL Medical, LLC 67871-111 67871-111-04 2 BOTTLE in 1 CARTON (67871-111-04) > 118 mL in 1 BOTTLE (67871-111-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength8,500 IU/ML
Approval Date:Apr 9, 1998TE:RLD:Yes
Patent:9,469,847Patent Expiration:Feb 7, 2034Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot